Omeprazole Market Analysis

Dosage Form (Capsule, Tablet, Powder)

The capsule segment is expected to propel the omeprazole market growth in the forecast period. The capsule segment is expected to occupy 52% of the largest market share by 2035. Additionally, the capsule is expected to cross 1800 Million by the end of 2035. The tablets are easy to handle and inexpensive. Also, 2020 will see a 24% increase in total medication use to 4.5 trillion doses. More than half of the world's population will take more than one dose of medication per person per day, up from one-third in 2005, with India, China, Brazil, and Indonesia leading the way. This may result in the expansion of industry growth.

Indication (Duodenal Ulcer, Gastric Ulcer, Gastroesophageal Reflux, Erosive Esophagitis)

The duodenal ulcer category is expected to drive market growth. This category was leading the market in 2019 as well. Duodenal ulcers are most commonly observed in the age groups of 25-55 years. With age, the incidence of peptic ulcer increased to a peak of 28.8% in the 5th decade of life. Duodenal ulcers are thought to affect 5 to 15% of people in the West, according to numerous studies that have assessed their prevalence. These factors are driving the growth of this segment. 

Our in-depth analysis of the global market includes the following segments: